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MeCP2 Is a Transcriptional Repressor with
Abundant Binding Sites in Genomic Chromatin
Xinsheng Nan, F. Javier Campoy,* and Adrian Bird repress even strong promoters, whereas low densities
(for example, 1 per 100 bp) can repress weak promotersInstitute of Cell and Molecular Biology
but have no effect on strong ones (Boyes and Bird,University of Edinburgh
1992). A third parameter is the location of methyl-CpGEdinburgh EH9 3JR
with respect to the promoter of the gene. Several studiesUnited Kingdom
have suggested that methylation needs to be close to
the promoter to be effective (Keshet et al., 1985; Murray
and Grosveld, 1987). Moreover remote and promoter-Summary
proximal methyl-CpGs can collaborate to bring about
silencing (Hug et al., 1995). Others have reported thatMeCP2 is an abundant mammalian protein that binds
silencing can occur even when all methylated sites areto methylated CpG. We have found that native and
relatively distant from the promoter (Kass et al., 1993).recombinant MeCP2 repress transcription in vitro from
Data concerning the need for the reporter gene to bemethylated promoters but do not repress nonmethyl-
assembled into chromatin is also somewhat inconsis-ated promoters. Repression is nonlinearly dependent
tent. A methylated thymidine kinase gene was ex-on the local density of methylation, becoming signifi-
pressed normally for several hours following microinjec-cant at the density found in bulk vertebrate genomic
tion into cultured cell nuclei as naked DNA but wasDNA. Transient transfection using fusions with the
subject to immediate methylation-dependent repres-GAL4 DNA binding domain identified a region of
sion after injection as chromatin (Buschhausen et al.,MeCP2 that is capable of long-range repression in
1985; 1987). By contrast, rapid repression of severalvivo. Moreover, MeCP2 is able to displace histone H1
promoters was seen in in vitro or transient transfectionfrom preassembled chromatin that contains methyl-
assays under conditions where chromatin assembly wasCpG. These properties, together with the abundance
absent or far from complete (Boyes and Bird, 1991;of MeCP2 and the high frequency of its 2 bp binding
1992). The somewhat variable results in different experi-site, suggest a role as a global transcriptional repres-
mental systems with respect to the requirement for chro-sor in vertebrate genomes.
matin assembly and potential for action-at-a-distance
by methylation may indicate that more than one media-
Introduction tor of repression is under study.
Definitive identification of the mediators of methyla-
Cytosine in the sequence CpG is frequently methylated tion-dependent gene silencing depends on the bio-
in the vertebrate genome. The effects of this modifica- chemical detection of proteins with an affinity for methyl-
tion ongene activity have been investigated by introduc- CpG. Following the initial demonstration that extracts
ing methylated reporter gene constructs into cells and of human cells contain proteins that bind to methylated
cell-free extracts. Experiments of this type established DNA (Huang et al., 1984), a number of proteins have
that methyl-CpG often interferes with the process of been identified. Several of these appear to bind to
transcription (Stein et al., 1982; Vardimon et al., 1982). methyl-CpG without regard to flanking sequences.
There are two general mechanisms by which this is MeCP1 is a widely expressed protein that can form a
thought to happen. Either methylation at a specific site complex with DNA, provided that the density of methyl-
repels the transcription factors that would normally bind ated sites exceeds a threshold level (Meehan et al.,
there (for example, Watt and Molloy, 1988), or methyla- 1989). There is good evidence that this activity represses
tion attracts proteins that themselves mediate repres- transcription from methylated reporter genes in vitro
sion (reviewed by Tate and Bird, 1993). It is likely that and in vivo (Boyes and Bird, 1991), though the mecha-
both mechanisms contribute to methylation-mediated nism has not yet been determined. Other candidates for
gene silencing, but the evidence so far suggests that generalized methyl-CpG binding proteins that repress
indirect repression via methyl-CpG binding proteins is transcription are histone H1 and MDBP-H1. There is
the primary factor in most cases. This follows from the disagreement in the literature regarding the influence of
observation that many fully methylated genes can be DNA methylation on H1 binding; some have detected an
transcribed at nearly normal rates under conditions effect (Levine et al., 1993; Johnson et al., 1995; McArthur
where methyl-CpG binding proteins are effectively ab- and Thomas, 1996), whereas others have not (Higurashi
sent (Boyes and Bird, 1991; Levine et al., 1991). and Cole, 1991; Campoy et al., 1995; Nightingale and
The nature of theproteins that are attracted by methyl- Wolffe, 1995). The two studies that tested the affinity of
ated DNA can be deduced to some extent from the H1 for DNA assembled into chromatin (rather than naked
parameters that affect repression. Two interacting pa- DNA) found no measurable preference for methylated
rameters are the density of methyl-CpG and strength of DNA (Campoy et al., 1995; Nightingale and Wolffe, 1995).
the promoter (Boyes and Bird, 1992; Hsieh, 1994). High The activity known as MDBP-H1 has been detected in
methylation densities (for example, 1 per 10 bp) can chicken but not yet in mammalian cells (Jost and Hof-
steenge, 1992). Purified fractions are reported to bind
to methylated reporter genes and to inhibit transcription.* Present address: Dpto. Bioquıˆmica y Biologia Molecular-A, Edificio
This study concerns MeCP2 (Lewis et al., 1992; Mee-de Veterinaria, Universidad de Murcia, Apdo. 4021, E-30071 Es-
pinardo, Murcia, Spain. han et al., 1992), an abundant chromosomal protein with
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a high affinity for methyl-CpG pairs (that is two base-
paired CpGs, each methylated). The methyl-CpG bind-
ing domain, or MBD, is 80 amino acids in length and is
essential for chromosomal localization of the protein
(Nan et al., 1993; 1996). Mouse cells that are deficient
in methyl-CpG show inefficient localization of MeCP2
to chromosomes. Thus MeCP2 is a methyl-CpG binding
protein in vivo as well as in vitro (Nan et al., 1996).
Analysis of the functional role played by MeCP2 has
been crudely assessed by disruption of the X-linked
gene in mouse embryonal stem cells. Cells lacking the
gene are viable, but are incapable of supporting mouse
development (Tate et al., 1996). The embryonic lethal
phenotype of MeCP22 mice, while suggesting that
MeCP2 is an essential mediator of the biological effects
of DNA methylation, does not betray the nature of the
biochemical lesion. In this study, we have investigated
the possibility that MeCP2 is a transcriptional repressor.
Previous efforts to test this foundered because the en-
riched fractions that were tested repressed transcription
indiscriminately (Meehan et al., 1992). We now find that
MeCP2 possesses an effective transcriptional repres-
sion domain. The abundance of methyl-CpG in the ge-
nome and ability of MeCP2 to interact with nucleosomal
chromatin, even in the presence of histone H1, suggest
that the effects of MeCP2 may be generally felt through-
out the methylated majority of the genome.
Results
MeCP2 Specifically Represses Methylated
Genes In Vitro
MeCP2 was purified from rat brain using ion-exchange
and affinity chromatography. Because the protein natu-
rally contains a run of 7 histidines, we utilized a nickel-
agarose affinity step, and this resulted in an MeCP2
preparation that gave a single Coomassie blue–stained
band on an SDS–polyacrylamide gel (not shown). Previ-
ous studiesshowed that enriched MeCP2 from rat tissue Figure 1. MeCP2 Represses Transcription from Methylated AdML
inhibited transcription equally from both methylated and Promoter In Vitro
unmethylated templates in an in vitro transcription assay Transcription from nonmethylated (M2) and methylated (M1) ade-
using rat liver nuclear extract (Meehan et al., 1992). Be- novirus major late promoter (AdML) in vitro using a HeLa cell nuclear
extract.cause this result might have been affected by impurities
(A) Native MeCP2 purified from brain was incubated with AdMLin that MeCP2 preparation, we repeated the experiment
reporter before transcription was initiated. The amount of MeCP2using the affinity-purified material. Native MeCP2 was is indicated in mg. Transcripts were detected by primer extension
preincubated with an unmethylated or methylated re- to give a product of 85 nucleotides (arrow). Lane C is a negative
porter that contained the adenovirus major late (AdML) control in which transcripts were not added to the primer extension
mix.promoter. HeLa nuclear extract and ribonucleotide tri-
(B) As above, but using MeCP2 fusion proteins expressed in bacte-phosphates were added to initiate transcription, and the
ria. A diagrammatic representation of recombinant GST-MeCP2 fu-amount of product was measured by primer extension.
sion proteins is shown below, including intact MeCP2, MeCP2 with
In the absence of MeCP2, transcription from methylated an internal deletion in the methyl-CpG binding domain (D99–126),
DNA was slightly lower than that from unmethylated and MeCP2 with a large C-terminal deletion (1–162). MeCP2 is
shaded and MBD is shown in black.DNA (Figure 1A). This is probably due to the presence
(C) A diagram of the AdML promoter, showing start site of transcrip-of MeCP1 in the transcription extract (Boyes and Bird,
tion (hooked arrow), position of the primer used for the reverse1991; see below). Addition of purified MeCP2 strongly
transcriptase assay (arrow), and transcription factor binding sites
repressed transcription from methylated DNA (Figure that are important for promoter activity. The XhoI and BamHI sites
1A). Transcription from the nonmethylated template was delineate the fragment used for patch methylation studies (see Fig-
not repressed, but was somewhat enhanced in the pres- ure 3C). Below is a colinear map of CpG sites. A plot of CpG sites
for the entire AdML reporter plasmid is shown in Figure 4C.ence of MeCP2.
(D) Repression by MeCP2 can be alleviated by addition of methyl-Equivalent results were obtained using recombinant
ated competitor DNA in vitro. All reactions contained carrier (com-MeCP2 purified from E. coli as a GST fusion protein
petitor) DNA that was either nonmethylated (2) or methylated (1).
(Figure 1B). Once again, methylated template was re- The expected product of 85 nucleotides is indicated by arrow. All
pressed in the presence of MeCP2, whereas nonmethyl- panels are derived from thesame gel and thesame autoradiographic
exposure.ated template was not repressed. Moderate stimulation
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of transcription from the nonmethylated template was problem, we replaced MBD with the DNA binding do-
main of the yeast transcription factor GAL4 and assayedobserved in the presence of fusion MeCP2. Methylation-
dependent repression was also observed with a reporter for the ability of this fusion protein to repress a reporter
gene that contained GAL4 binding elements. A reporterdriven by the human b-actin promoter. MeCP2 elimi-
nated transcription from the methylated construct, but was constructed by insertion of five GAL4 binding sites
into a BglII site upstream of the b-actin promoter in theweakly stimulated transcription from its nonmethylated
counterpart (not shown). reporter pbbgeoN/B, resulting in pbG5BglII (Figure 2A).
Effectors were constructed by fusing parts of MeCP2To test whether these effects were associated with
binding of MeCP2 to methylated DNA, a modified bacte- with the GAL4 DNA binding domain (Figure 2A). Expres-
sion of the effectors was driven by the CMV promoter,rially expressed MeCP2 that carried a 27 amino acid
deletion (D99–126) in the methyl-CpG binding domain and correct expression of products of the appropriate
size was checked by probing Western blots with an anti-(MBD) was tested. The internal deletion is known to
abolish binding to methylated DNA (Nan et al., 1996). GAL4 antibody (Figure 2C) and anti-MeCP2 antibody
(not shown). The effects of the GAL4-MeCP2 fusion pro-The mutant MeCP2 did not repress transcription from
methylated or unmethylated DNA (Figure 1B). Instead, teins on transcription were tested by cotransfection of
increasing amounts of effector construct with reporterstranscription from both templates was moderately stim-
ulated. The results indicate that repression depends that either did or did not have GAL4 binding sites near
the promoter. The results showed that a region ofupon binding of MeCP2 to the reporter DNA. Stimulation
appears to be an indirect effect that does not require MeCP2, when fused to the GAL4 binding site, strongly
inhibited expression of pbG5BglII. Examples of the dataDNA binding. We next asked whether DNA binding is
sufficient to repress in the absence of the C-terminal are shown in Figure 2B, and the results are summarized
in Figure 2D. Based on the results of the deletion analy-half of the protein. Amino acids 1–162 of MeCP2 include
the MBD and bind strongly to methylated DNA in vitro sis, it was possible to map a transcription repression
(TR) domain between amino acids 207 and 310 (Figure(Nan et al.,1993). Addition of this protein to the transcrip-
tion reactions gave weak repression of the methylated 2D). To test the requirement of the entire region for
repression, two internal deletions of 9 amino acids wereconstruct in comparison with an equimolar amount of
full-length MeCP2 (Figure 1B). This finding suggests that also made within the TR domain. Deletions of amino
acids 221–229 and 241–249 both abolished repressionthe C-terminal half of the protein is needed for efficient
repression in vitro, and it implies that the binding of activity (Figure 2D). The TR domain of MeCP2 is very
basic, comprising 26% lysine and arginine. It is also richprotein to CpG sites is not by itself sufficient to inhibit
transcription. in nonpolar amino acids: alanine (12.5%), valine (10.5%),
and proline (8%).The dependence of repression on MeCP2 binding to
DNA was further demonstrated by addition of methyl- It was noticeable that all constructs that contained
the TR domain also weakly inhibited transcription fromated carrier DNA to the in vitro transcription reactions.
Standard transcription reactions contained 0.9 mg of the control plasmid that lacks GAL4 binding sites (for
example, Figure 2B). It seems unlikely that this effect isunmethylated plasmid DNA as carrier. When this was
methylated at all CpGs, transcription from unmethylated due to nonspecific binding of the GAL4 domain to this
plasmid, as nonspecific binding by the GAL4 domaintemplates was unaffected (Figure 1D, compare lanes
1 and 3), but transcription from methylated template is very low. More likely, MeCP2 inhibits transcription
indirectly by interacting with factor(s) that are neededincreased somewhat even in the absence of MeCP2
(Figure 1D, compare lanes 5 and 7), leading to equal for efficient transcription. The interactions may be ineffi-
cient when the TR domain is not tethered to DNA, butexpression from methylated and unmethylated controls
(Figure 1D, compare lanes 1 and 7). This effect is proba- may be similar in kind to those responsible for repression
by bound TR domain.bly due to removal of low levels of MeCP1 in the tran-
scription extract that weakly inhibited the methylated
promoter (see Boyes and Bird, 1991). Repression of
MeCP2 Can Repress Transcriptionmethylated reporter by MeCP2 was completely reversed
at a Distanceby addition of methylated carrier DNA (Figure 1D, com-
The GAL4 binding sites in pbG5BglII are approximatelypare lanes 6 and 8). This shows that the methylated
400 bp upstream of the transcription start site of thepromoter can be transcribed as efficiently as a nonmeth-
human b-actin promoter. To test the effect of distanceylated promoter when MeCPs 1 and 2 are absent (see
from the promoter on repression, we inserted one oralso Boyes and Bird, 1991; Levine et al., 1991; Boyes
two 887 bp fragments of plasmid DNA between GAL4and Bird, 1992).
binding sites and the promoter of pbG5BglII (Figure 3A).
This resulted in two new reporters, pb-887-G5 and pb-
1774-G5, with about 1300 and 2100 base pairs of DNAMeCP2 Contains an Active Transcriptional
Repression Domain separating the GAL4 binding-sites from the transcription
start site (Figure 3A). These reporters and control re-An in vivo assay for the effect of MeCP2 on transcription
inmammalian cellsby transient transfection is not possi- porter were tested by their response to the activator
GAL4-VP16 and the repressor GAL4-MeCP2(207–492)ble, as methylation of all CpG sites in a reporter gene
invariably causes complete suppression of the gene by in a transient transfection assay. As shown in Figure 3A
(left panel), GAL4-VP16 stimulated expression of report-endogenous mechanisms (data not shown; see Stein et
al., 1982; Boyes and Bird, 1991). To circumvent this ers from a distance of more than 2 kb, but the efficiency
Cell
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Figure 2. MeCP2 Contains a Transcriptional
Repression Domain That Functions When
Fused to a Heterologous DNA Binding
Domain
(A) Maps of reporter and control reporter con-
structs that respectively contain or do not
contain 5 copies of the GAL4 DNA binding
site. The general structure of effector con-
structs in which fragments of the MeCP2 cod-
ing sequence were fused to the GAL4 DNA
binding domain are also shown.
(B) Examples of transcription from reporter
(closed circles) or control reporter (open cir-
cles) in the presence of increasing amounts
of different effector genes, following transient
transfection into L929 cells.The four effectors
contain, respectively, coding sequences for
amino acids 170–310, 170–300, 207–392, and
230–396 of MeCP2.
(C) Western blot analysis of GAL4-MeCP2 fu-
sion proteins synthesised after transient trans-
fection of effector constructs into mouse
L929 cells. Deletion constructs are shown
above, and the repression activity of each is
indicated by a symbol beneath each lane.
(D) Map of the transcriptional repression do-
main in MeCP2. MeCP2 is diagrammed at the
top of the figure, showing the methyl-CpG
binding domain (MBD) and nuclear localiza-
tion signal (NLS). The scale represents amino
acid number. The transcriptional repression
(TR) domain is diagonally shaded. Below are
shown the regions of MeCP2 that were fused
with the GAL4 DNA binding domain (see Fig-
ure 2A) and each analyzed by transient co-
transfection with reporters as shown in Figure
2B. The presence (1) or absence (2) of GAL4
site-dependent repression is shown in the
righthand column. Numbers on the left show
coordinates of MeCP2 that were included in
the constructs. The minimal region that gave
repression is bounded by vertical broken
lines.
(Figure 2 continued on next page)
of activation declined somewhat with distance. Simi- plasmid. The effect of MeCP2 on transcription from
these reporters was tested in an in vitro transcriptionlarly, GAL4-TR repressed transcription at all tested dis-
tances from the promoter, and the strengthof repression assay (Figure 3B). As before (see Figure 1), MeCP2
slightly stimulated transcription from fully unmethylatedlessened with distance. Repression for pb-887-G5 and
pb-1774-G5 was reproducibly about 2-fold stronger reporter (vecM2/pM2) and strongly repressed fully
methylated reporter (vecM1/pM1). Plasmid constructsthan that for the control pbbgeoN/B, but was less strong
(about half) than that for pbG5BglII (Figure 3A, right in which methylation was confined to an 800 bp XhoI–
BamHI fragment (see Figure 1C) that includes the tran-panel). The results show that the TR domain of MeCP2
is capable of long-range repression. scription start site and all known transcription factor
binding sites (Reach et al., 1990; Garfinkel et al., 1990)The TR domain of MeCP2 can repress transcription
at a distance when fused to a GAL4 DNA binding site. in the promoter (vecM2/pM1) were repressed nearly
as strongly as fully methylated constructs. Molecules inCan intact MeCP2 repress transcription when bound to
methylated sites that are remote from a promoter? To which methylation was present in all parts of the plasmid
except the XhoI–BamHI promoter fragment (vecM1/answer this question, we used the religation procedure
illustrated in Figure 3B to construct chimeric AdML re- pM2) also showed repression compared to nonmethyl-
ated controls, although the effect was less severe thanporters with methylation in different parts of the circular
MeCP2 Is a Transcriptional Repressor
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methyl-CpG in mammalian genomes lies within this
range (see Discussion).
Genome-Wide Distribution of MeCP2
Immunofluorescence staining has shown that MeCP2
is a chromosome-associated protein. In mouse, it is
concentrated in heterochromatin that contains methyl-
CpG-rich satellite DNA, whereas in rat, staining is more
uniform (Lewis et al., 1992; Nan et al., 1996). We reas-
sessed the distribution of endogenous MeCP2 and of a
stably expressed exogenous MeCP2 fusion protein in
rat cells using reagents of higher specificity and ex-
tended the analysis to African green monkey and human
chromosomes. Fusion protein was visualized by indirect
immunofluorescence staining using anti-b-galactosi-
dase antibody, and endogenous protein was detected
with an anti-rat MeCP2 antibody. The results are shown
for Rat1A cells (Figure 5), but equivalent results were
obtained for monkey kidney COS7 cells and human
HeLa cells (not shown). In each case, MeCP2 was
broadly distributed throughout chromosome arms.
MeCP2 Can Bind to Chromatinthat seen with the other methylated constructs. Since
the methylation on plasmid vecM1/pM2 lies outside and Displace Histone H1
Transcription factors often have difficulty in interactingthe promoter region (see Figure 1C), the effect on tran-
scription is unlikely to be due to steric occlusion of with DNA binding sites that are wrapped in chromatin
(Lorch et al., 1987; Losa and Brown, 1987; Laybourntranscription factors. A more likely mechanism is that
MeCP2 contains an active repression domain that inter- and Kadonaga, 1991; Li et al., 1994). To test whether
MeCP2 is able to bind methylated DNA in a chromatinacts with the transcriptional machinery or the initiation
complex to prevent transcription. The results parallel context, we assembled plasmids into chromatin using
a Xenopus oocyte extract. As reported earlier (Campoythose obtained in vivo in that they show significant but
weakened effects of MeCP2 on transcription when the et al., 1995), methylated and nonmethylated plasmids
gave polynucleosomal chromatin with equal efficiency,DNA binding sites are remote from the promoter. The
magnitude of the in vivo and in vitro effects is different, as judged by micrococcal nuclease digestion of the
products (data not shown). Two plasmids of greatly dif-however, as repression appears to decline more sharply
with distance in vitro. It is not clear if this is due to the fering sizes, one methylated at all CpGs and the other
nonmethylated, were incubated simultaneously with thedifferent DNA binding domains in the two experiments
or to other differences between the in vivo and in vitro Xenopus extract. After assembly overnight, 32P-labeled
MeCP2 was added and the differently sized “minichro-assays.
mosomes” were resolved by centrifugation in sucrose
gradients. The results showed that MeCP2 was able toInfluence of Methyl-CpG Density on Repression
The effects of DNA methylation on transcription are de- bind to preassembled chromatin and was specifically
localized to whichever minichromosome containedtermined by several parameters, including density of
methyl-CpG (Boyes and Bird, 1992; Hsieh, 1994). To test methylated DNA (Figures 6A and 6B). Incorporation into
the nonmethylated minichromosome was negligible.whether the influence of MeCP2 was affected by this
parameter, AdML reporter was methylated to different The Xenopus extract contains a relatively small
amount of a histone H1-like protein, and assembledextents by using different cytosine methyltransferases
alone or in combination. Methylation by CpG methylase chromatin lacks H1 (Hock et al., 1993; J. C., unpublished
data). To investigate whether MeCP2 can access its(M.SssI) gave a density of 7.2 methyl-CpGs/100 bp.
M.HhaI and M.HpaII methyltransferases together gave binding sites in the presence of H1, we added 32P-
labeled H1 from rat kidney (Campoy et al., 1995) to the1.35 methyl-CpGs/100 bp and separately gave 0.76 and
0.59 methyl-CpGs/100 bp, respectively (Figure 4C). chromatin assembly reactions. As shown previously, H1
distributed equally between methylated and nonmethyl-Transcription was found to be strongly dependent on
the density of methylation over a range of added MeCP2 ated minichromosomes, showing no detectable prefer-
ence for methylated DNA (Campoy et al., 1995). Whenconcentrations (Figure 4A). Relative transcription for dif-
ferently methylated reporters in the presence of 2 mg of preassembled chromatin that contained H1 was chal-
lenged with MeCP2, a specific loss of H1 label in theMeCP2 was plotted against number of methyl-CpGs/
100 bp (Figure 4B). The resulting curve shows that re- methylated minichromosome was observed (Figure 6C).
This suggests that MeCP2 can displace histone H1 frompression was not linearly related to the density of
methyl-CpGs, but appeared suddenly at between 0.5 chromatin in order to access its binding sites. Competi-
tion for binding sites between H1 and MeCP2 indicatesand 1 methyl-CpGs/100 bp. The average density of
Cell
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Figure 3. The Transcriptional Repression
Domain of MeCP2 Functions at a Distance In
Vivo and In Vitro
(A) The basic in vivo reporter, which contains
5 GAL4 binding sites (closed box) located ap-
proximately 400 bp upstream of the b-actin
transcription start site (see Figure 2A), was
modified by insertion of one or two copies of
an 887 bp fragment of plasmid vector (cross-
hatched box). Control reporter lacked GAL4
binding sites altogether. A GAL4-VP16 fusion
activator was tested by cotransfection with
the four constructs (left panel). Solid bars
show the level of expression in the absence
of activator normalized to a level of 1, and
shaded bars show relative activity in the pres-
ence of activator. The effects of GAL4 fusion
with the transcriptional repression (TR) do-
main of MeCP2 are shown in the right panel.
Expression levels in the absence of GAL4-TR
are normalized to a level of 100% (closed
bars), with shaded bars showing relative ex-
pression in the presence of GAL4-TR.
(B) Repression from a distance by MeCP2 in
vitro. The scheme for assembly of chimeri-
cally methylated expression constructs using
the adenovirus major late promoter construct
(see Figure 1) is shown above. Below are
maps of methylated CpGs (vertical lines) in
the four possible chimerically methylated
constructs. Expression levels are quantitated
by a histogram (right) relative to expression
of each construct in the absence of MeCP2
(100%).
that MeCP2, like H1, may bind to linker DNA. Further onto a different DNA binding domain without loss of
function. These properties argue that the effect ofwork is required to determine binding sites directly.
Addition of increasing amounts of MeCP2 suggested MeCP2 on transcription is not a consequence of effects
on chromatin structure per se, but is due to the presencethat not all H1 could be displaced by MeCP2. Competi-
tion appeared to plateau when about 40% of resident of an active repression domain that interferes with basal
or regulatory components of the transcription machin-H1 had been displaced (Figure 6D). It is possible that
some linkers lack appropriately placed methyl-CpGs or ery. The MeCP2 repression domain has no clear homol-
ogy with other known active repressors (reviewed bylack methylated sites altogether. Average repeat length
in this chromatin as determined by micrococcal nu- Hanna-Rose and Hansen, 1996), and the potential for
interaction with transcription factors has not yet beenclease digestion is 160 bp (not shown), and therefore,
average linker length is about 16bp. The smaller plasmid investigated. Repression first became evident in vitro
when the density of methyl-CpGs approached about(pUC18) contains one CpG per 12 bp, on average. Thus,
it is likely that a significant fraction of linkers contain one per 100 bp. Above this density, repression was
invariably strong, whereas below it, transcription wasno methylated site. MeCP2 would not be expected to
displace H1 from this subset of linkers. not reduced. One possible explanation is that there is
cooperation between MeCP2 molecules at some level.
For example, one bound molecule may be insufficient,Discussion
but multiple bound molecules may collaborate to
achieve repression. Another possibility is that the cre-A Global Transcriptional Repressor
The results described here show that MeCP2 is a tran- ation of extra binding sites increases the probability
that an MeCP2 molecule will be close enough to thescriptional repressor whose potency depends on the
density and location of methyl-CpGs near a promoter. promoter to cause silencing. Further work is required
to distinguish rigorously between these and other possi-Repression works from a distance in the absence of
chromatin, and the repression domain can be grafted bilities.
MeCP2 Is a Transcriptional Repressor
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Figure 4. Repression by MeCP2 Depends on
Density of Methylation
(A) Each construct was tested for expression
in vitro in the presence of varying amounts
of MeCP2-GST fusion. Expression of each
construct in the absence of MeCP2 was set
at 100%.
(B) A plot of the expression data at 2 mg
MeCP2 versus density of methylation per 100
base pairs. The shaded bar shows the ap-
proximate average density of methyl-CpG in
the mammalian genome.
(C) The AdML promoter construct was meth-
ylated using M. SssI, M.HhaI, M. HpaII,
M.HhaI 1 M. HpaII, and no enzyme. The posi-
tions of methyl-CpG sites after each treat-
ment are shown (vertical lines).
More Binding Sites Than Protein requires treatment with very high concentrations of salt
(.0.5 M), further supporting the view that most MeCP2 isIt is likely that most, if not all, MeCP2 molecules are
bound to their cognate binding sites in vivo. Immunoflu- tightly bound in the nucleus. There is more than enough
methyl-CpG in genomic DNAto preoccupy all moleculesorescence shows that MeCP2 is associated with chro-
mosomes at metaphase, and in mouse, where thebulk of of MeCP2. A typical diploid nucleus contains approxi-
mately 4 3 107 methyl-CpGs, whereas quantitativemethyl-CpG is in satellite DNA, prominent foci of MeCP2
localization are apparent in interphase nuclei (Lewis et Western blots suggest that the number of MeCP2 mole-
cules is of the order of 106 molecules per nucleus (6 3106al., 1992; Nan et al., 1996). Release of MeCP2 from nuclei
Figure 5. Broad Distribution of MeCP2 on
Rat Metaphase Chromosomes by Immuno-
fluorescence
Normal Rat 1A cells or cells that had been
stably transfected with a MeCP2-bgeo fusion
gene (1; for construct, see Nan et al., 1996)
were spread for immunofluorescence analy-
sis with anti-MeCP2 antibody or, in the case
of transfectants, anti-b-gal antibodyalso. The
anti-b-galactosidase antibody gave back-
ground staining on untransfected cells (not
shown). DNA is stained with Hoescht 33258.
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Figure 6. MeCP2 Binds to Methylated Chro-
matin In Vitro and Can Displace Histone H1
(A and B) Plasmids of 2.7 kb and 14.6 kb were
used to facilitate separation of assembled
minichromosomes. Either the large (A) or the
small (B) plasmid was methylated at all CpGs
(M1), and after mixing with the nonmethyl-
ated counterpart (M2), both were incubated
with a Xenopus oocyte extract overnight. Mi-
crococcal nuclease digestion showed the
nucleosomal ladder that is characteristic of
assembled chromatin (see Campoy et al.,
1995). After assembly, 32P-labeled MeCP2
was added, and the minichromosomes were
resolved by sucrose gradient centrifugation.
DNA was located by Southern blotting (band
intensity), and MeCP2 was located by scintil-
lation counting (cpm). (C) The chromatin
assembly systemwas supplementedby addi-
tion of 32P-histone H1, which became incor-
porated into methylated and nonmethylated
minichromosomes equally. Addition of unla-
beled MeCP2 reduced incorporation of H1
into the methylated minichromosome com-
pared with an identical aliquot that was not
treated with MeCP2.
(D) Effect of increasing concentrations of
MeCP2 on preincorporated H1.
molecules pernucleus in brain) (X. N., unpublished data). Riggs and Pfeifer, 1992) and at certain imprinted genes
(reviewed by Razin and Cedar, 1994). An interesting con-Even if binding were to be confined to internucleosomal
linker DNA, it seems unlikely that MeCP2 could saturate sequence of repression without full site-occupancy is
that in vivo footprinting would be unlikely to detect theits available binding sites in the genome. Direct evidence
for an excess of binding sites over protein comes from presence of MeCP2. Successful in vivo footprinting de-
pends on nearly complete occupation of specific sitestransient transfection of cultured mouse cells. Overex-
pressed MeCP2 shows clear localization to heterochro- and would not detect the low occupancy per site pre-
dicted here. Thus, the absence of in vivo CpG footprintsmatic foci, indicating that there are many sites left unoc-
cupied by endogenous MeCP2 (Nan et al., 1996). in a methylated CpG island (Pfeifer et al., 1990) does
not necessarily rule out the presence of MeCP2.The excess of binding sitesover protein makes it likely
that no two homologous chromosomes will show the Specific protection of methylated sites against
nuclease attack was detected in mouse nuclei (Ante-same distribution of bound MeCP2. The degree of
MeCP2-mediated repression experienced by a region quera et al., 1989). The effect was particularly pro-
nounced in brain, which is also the tissue where weof the genome will therefore vary between homologous
chromosomes, depending on the proximity of the near-
est MeCP2 (Figure 7). When the concentration of MeCP2
is high, as it is in brain, the environment is likely to
be consistently repressive in methylated regions of the
genome. On the other hand, CpG islands, which are
methylation-free, will be consistently free of repression
(Figure 7). When the MeCP2 concentration is low, a
region of bulk genomic DNA will experience, on average,
little repressive effect. The extent of global repression
due to MeCP2 is therefore dependent on the abundance
of MeCP2 in that nucleus.
Repression is also dependent on the local density of Figure 7. Consequences of the Molar Excess of Methyl-CpGs over
methyl-CpG and may be strong at a methyl-CpG cluster, Molecules of MeCP2
even when the proportion sites occupied by MeCP2 is Four DNA strands are shown with methyl-CpGs (closed circles) and
nonmethylated CpGs (open circles). Open triangles representlow (Figure 7). This follows from the finding that the
MeCP2 molecules with the range of repression from each moleculesilencing effect of MeCP2 can act over some distance,
shown as a shaded circle. Where the density of methylation is low,and therefore binding of the protein to different methyl-
different molecules have different distributions of MeCP2. WhereCpG moieties within a cluster will consistently silence
methyl-CpG density is high (in the center of the three upper strands),
a local promoter. Clustering of methylated CpGs is repression is felt throughout the methylated cluster even though a
known to occur within methylated CpG islands, for ex- minority of sites are occupied. Nonmethylated clusters of CpG (for
example, CpG islands) are always free of repression (bottom strand).ample, on the inactive X chromosome (reviewed by
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to makeconstructs capable of expressing fusionsbetween the GAL4find the highest concentration of MeCP2. Embryonal
DNA binding domain and deletions of MeCP2. DNA fragments en-carcinoma cells do not express MeCP2 and showed
coding parts of MeCP2 were amplified by PCR and cloned intovery low levels of methyl-CpG protection. Stoichiometric
BamHI/SalI-digested pCMV-GAL4. Plasmid pGBT-VP16 was con-
calculations suggest that the amount of MeCP2 in a structed by replacing the XhoI/SalI fragment of pGBT9 with the
brain nucleus may beapproximately equal to the number XhoI/SalI fragment from pJL-VP16 (Chasman et al., 1989). Vectors
expressing b-geo (a fusion between b-galactosidase and the neo-of available methyl-CpG sites in internucleosomal link-
mycin-resistance gene) were constructed as follows. DNA frag-ers. We propose that the nuclease resistance of methyl-
ments containing 5 GAL4 binding sites were obtained by BamHICpGs in brain (and to a lesser extent in other tissues)
and HindIII digestion of pG5E4T (Lin et al., 1988; Kerrigan et al.,is due to their protection by bound MeCP2.
1991). This fragment was blunt-ended and inserted into BglII site
(upstream of human b-actin promoter) of pbbgeoN/B (Nan et al.,
1996) to generate pbG5BglII. Plasmids pb-887-G5 and pb-1774-G5Chromatin Is Not a Barrier to MeCP2 Binding
were constructed by insertion of 887 bp NlaIII fragment of pBlue-Several transcription factors that affect transcription
script II KS2 into the SphI site located between GAL4 binding sitespositively or negatively are unable to access their bind-
and the human b-actin promoter. Construction of pAdomal was
ing sites on DNA when nucleosomes are present (Losa described by Heiermann and Pongs (1985). Constructs with methyl-
and Brown, 1987; Laybourn and Kadonaga, 1991; Li et ation at different regions were made following the procedure shown
al., 1994). Evidencesuggests that the removal or remod- in Figure 3B.
eling of nucleosomes near a promoter is a prerequisite
Purification of MeCP2 from Rat Brainfor assembly of a functional transcription complex (re-
MeCP2 was isolated from rat brain nuclei essentially as describedviewed by Struhl, 1996), presumably because this re-
(Lewis et al., 1992), but with the following modifications. Fractionsmovesa blockto factorbinding. MeCP2 does not appear
containing MeCP2 eluted from a Fractogel EMD SO32-650(M) col-
to require prior disruption of nucleosomal chromatin in umn (Merck) were pooled and dialyzed against 20 mM HEPES (pH
order to bind to the genome. At a gross level, we have 7), 5 mM KCl, 1.5 mM MgCl2, 1 mM EGTA, 10% glycerol, 10 mM
b-glycerophosphate, and 20 mM imidazol. The dialyzed sample wasobserved that large numbers of extra MeCP2 molecules
loaded onto a nickel column (Ni21-NTA-agarose, from QUIAGEN),produced during transient expression find appropriate
and eluted with increasing concentrations of imidazol. MeCP2 wasbinding sites in mouse heterochromatin (Nan et al.,
eluted by 100–200 mM imidazol. Finally, the fractions containing1996). The simplest explanation for this observation is
MeCP2 were concentrated using a Fractogel SO32-650(M) column,
that MeCP2 can directly access sites in chromatin. We dialyzed, and stored at 2808C. Purified MeCP2 gave a single Coo-
attempted to reconstruct this situation in vitro by assem- massie blue–stained band on an SDS–polyacrylamide gel (not
shown).bling plasmid DNAs into chromatin using a Xenopus
extract and then challenging the preassembled chroma-
Purification of Recombinant GST-MeCP2 Fusion Proteinstin with MeCP2. Again, localization occurred specifically
A GST-MeCP2 expression vector was derived from pGEX-3c (Nanto chromatin that contained methylated DNA. We placed
et al., 1993). Expression was induced in E. coli XL-1 Blue cells by
further obstructions in the way of MeCP2 by incorporat- addition of 0.2 mM IPTG. Cells were resuspended in lysis buffer (10
ing histone H1 into the chromatin. MeCP2 specifically mM sodium phosphate [pH 7.2], 50 mM NaCl, 4 M urea, and 10%
displaced histone H1 from minichromosomes that con- glycerol) and sonicated. Supernatant was loaded over Fractogel
SO32 column equilibrated with lysis buffer. After extensive washtained methylated DNA. The results suggest that MeCP2
with lysis buffer, the column was washed with 2 vol of 0.42 M NaCldoes not require exposed DNA, but can interact with
buffer (0.42 M NaCl, 3.75 M urea, 10 mM sodium phosphate [pHchromatin, probably by binding to the internucleosomal
7.2], and 10% glycerol). Fusion protein was eluted with 1 M NaCl
linker. buffer (1 M NaCl, 10 mM sodium phosphate [pH 7.2], and 10%
glycerol). The fraction containing fusion protein was loaded over
Ni21-NTA-agarose column equilibrated with 1 M NaCl buffer. TheTranscriptional Noise Reduction?
column was washed with 3 vol of 20 mM imidazol in 0.5 M NaClVertebrates, unlike invertebrates, have CpG methylation
buffer. Fusion protein was eluted using 0.4 M imidazol containingthroughout the genome (Tweedie et al., 1997). As a re- 0.5 M NaCl, 10 mM sodium phosphate (pH 7.2), and 10% glycerol.
sult, the 2 bp binding site of MeCP2 occurs once per Fusion protein fractions were dialyzed sequentially against 0.5, 0.25,
150 bp throughout most of the vertebrate genome. The 0.125, and 0.02 M NaCl buffer containing 10 mM sodium phosphate
and 10% glycerol.widespread presence of MeCP2 may impede transcrip-
tion initiation in a manner complementary to nucleo-
In Vitro Transcription Assaysomes and histone H1. Together, these independent
Native MeCP2 or bacterially expressed GST-MeCP2 fusion proteinsprocesses may provide a highly efficient system for re-
were incubated at room temperature for 30 min in 19.5 ml of buffer
ducing transcriptional noise from inappropriate or spuri- containing 8.2 mM HEPES (pH 7.9), 41 mM KCl, 3 mM MgCl2, 0.08
ous promoters (see Bird et al., 1995). Complex genetic mM EDTA, 0.2 mM DTT, and 8.2% glycerol in the presence of 0.1
programs required by differentiated cells may not run mg AdML promoter construct (pAdomal) or 0.2 mg human b-actin
promoter construct (pbbgeoN/B). Total amounts of DNA were madeefficiently in the presence of excess transcriptional
up to 1 mg by addition of plasmid pGEX-3c. Then 3 ml (8 units) ofnoise. The embryonic lethal phenotype of MeCP22 mice
HeLa nuclear extract (Promega) was added and incubated at roommay therefore be due to leaky repression of inappropri-
temperature for 10 min. Transcription was initiated by adding 2.5
ate promoters.
ml of NTP mix (5 mM each of ATP, CTP, GTP, and UTP) and allowed
to proceed for 60 min at 308C. Reaction was stopped by adding
100 ml of stop solution (20 mM EDTA [pH 8], 0.2 M NaCl, 1% SDS,Experimental Procedures
and 0.25 mg/ml glycogen) and 300 ml of 0.3 M sodium acetate.
Samples were extracted once with phenol:chloroform and once withConstruction of Plasmids
pCMV-GAL4 was constructed by insertion of a blunt-ended 0.9 Kb chloroform. After precipitation, samples were dissolved in 5 ml of
water. The level of transcription was determined by a primer exten-HindIII fragment from pGBT9 (Clontech) into the BamHI site of
pCMV-Bam-Neo (Baker et al 1990). The resulting plasmid was used sion assay according to the Promega protocol. Primers TAGCGCAG
Cell
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AAGTCATGCCCGCTTT and CGACGGTGACCAAGCTTGCTAGCT Boyes, J., and Bird, A. (1992). Repression of genes by DNA methyla-
tion depends on CpG density and promoter strength: evidence forwere used to determine transcription from AdML promoter and hu-
man b-actin promoter, respectively. Quantification of transcription involvement of a methyl-CpG binding protein. EMBO J. 11, 327–333.
products was done on a PhosphorImager (Molecular Dynamics) Buschhausen, G., Graessmann, M.,and Graessmann, A. (1985). Inhi-
using ImageQuant 3.3 software. bition of herpes simplex thymidine kinase gene expression by DNA
methylation is an indirect effect. Nucl. Acids Res. 13, 5503–5513.
Cell Culture and Transfection Buschhausen, G., Wittig, B., Graessmann, M., and Graessmann, A.
Transient transfections were performed by the DEAE-dextran (1987). Chromatin structure is required to block transcription of the
method with slight modification. Cells (5 3 105) were seeded in methylated herpes simplex virus thymidine kinase gene. Proc. Natl.
tissue culture dishes 60 mm in diameter and grown overnight before Acad. Sci. 84, 1177–1181.
transfection. Reporter plasmid (2 mg) and reference plasmid (2 mg)
Campoy, F.J., Meehan, R.R., McKay, S., Nixon, J., and Bird, A.
were cotransfected with different amounts of effector plasmid. The
(1995). Binding of histone H1 to DNA is indifferent to methylation at
total amount of DNA was made up to 6 mg using pCMV as carrier.
CpG sequences. J. Biol. Chem. 270, 26473–26481.
Two days after transfection, cells were harvested using reporter
Chasman, D.I., Leatherwood, J., Carey, M., Ptashne, M., and Korn-lysis buffer (Promega). b-galactosidase activity was assayed using
berg, R.D. (1989). Activation of yeast polymerase II transcriptionthe substrate ONPG (o-nitrophenyl-b-D-galactopyranoside) (Pro-
by herpes VP16 and GAL4 derivatives in vitro. Mol. Cell. Biol. 9,mega). To establish stable cell lines expressing MeCP2-geo fusion
4746–4749.protein, linearized DNA was transfected into cells by electroporation
at 1000 V, 25 mF in 0.4 mm cuvette. Cells were selected with G418 Garfinkel, S., Thompson, J.A., Jacob, W.F., Cohen, R., and Safer,
B. (1990). Identification and characterization of an adenovirus 2(Nan et al., 1996). Preparation of metaphase chromosome spreads
and immunofluorescence staining were described previously (Nan major late promoter CAP sequence DNA-binding protein. J. Biol.
Chem. 265, 10309–10319.et al., 1996).
Hanna-Rose, W., and Hansen, U. (1996). Active repression mecha-
Western Blot nisms of eukaryotic transcription repressors. Trends Genet. 12,
Transiently transfected cells were lysed, and the cell lysates were 229–234.
separated on 12% denaturing polyacrylamide gel and electroblotted Heiermann, R., and Pongs, O. (1985). In vitro transcription with ex-
onto a nitrocellulose filter. The filters were blocked with 2% nonfat tracts of nuclei of Drosophila embryos. Nucl. Acids Res. 13, 2709–
milk in TBST buffer (50 mM Tris [pH 8], 150 mM NaCl, and 0.1% 2730.
Triton X-100) and then incubated with 0.1 mg/ml rabbit polyclonal
Higurashi, M., and Cole, R.D. (1991). The combination of DNA meth-
anti-GAL4 (DBD) antibody (Santa Cruz Biotechnology) in TBST plus
ylation and H1 histone binding inhibits the action of a restriction
5% fetal calf serum. The secondary anti-rabbit-IgG antibody, conju-
nuclease on plasmid DNA. J. Biol. Chem. 266, 8619–8625.gated with peroxidase (Sigma), and ECL reagent (Amersham) were
Hock, R., Moorman, A., Fischer, D., and Scheer, U. (1993). Absenceused to develop the Western blot.
of somatic histone H1 in oocytes and preblastula embryos of Xeno-
pus laevis. Dev. Biol. 158, 510–522.
Assembly of Chromatin In Vitro
Hsieh, C.-L. (1994). Dependence of transcriptional repression onAssembly of supercoiled plasmid DNA into minichromosomes using
CpG methylation density. Mol. Cell. Biol. 14, 5487–5494.Xenopus oocyte extract was described by Campoy et al., (1995).
Mini-chromosomes were separated by sedimentation in a sucrose Huang, L.-H., Wang, R., Gama-Sosa, M.A., Shenoy, S., and Ehrlich,
gradient. Two plasmids of differing sizes, pUC18 (2.7 kb) and M. (1984). A protein from human placental nuclei binds preferentially
pHsr11.9 (14.6 kb), were used (Campoy et al., 1995). The plasmids to 5-methylcytosine-rich DNA. Nature 308, 293–295.
were methylated by CpG methylase (M.SssI). Rat histone H1 and Hug, M., Silke, J., Georgiev, O., Rusconi, S., Schaffner, W., and
recombinant GST-MeCP2 fusion protein were radiolabeled with pro- Matsuo, K. (1995). Transcriptional repression by methylation: co-
tein kinase C and [g-32P]ATP following the methods indicated by the operativity between a CpG cluster in the promoter and remote CpG-
manufacturers (Promega). rich regions. FEBS Lett. 379, 251–254.
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